Cinnatropin 10 mg is a pharmaceutical formulation commonly used for its antispasmodic and smooth-muscle relaxant properties. It helps relieve spasms and discomfort associated with gastrointestinal and biliary tract conditions by reducing abnormal musRead More
Active Substance:
Somatropin
Strength:
10 Mg
Hormone Type:
Recombinant Human Growth Hormone
Protein Length:
191 Amino Acids
Cinnatropin 10 mg is a pharmaceutical formulation commonly used for its antispasmodic and smooth-muscle relaxant properties. It helps relieve spasms and discomfort associated with gastrointestinal and biliary tract conditions by reducing abnormal muscle contractions. The medicine is designed to provide effective symptom control with targeted action on smooth muscles.
Key Characteristics
| Active Substance | Somatropin |
| Strength | 10 mg |
| Hormone Type | Recombinant human growth hormone |
| Protein Length | 191 amino acids |
| Molecular Weight | ≈22 kDa |
| Dosage Form | Lyophilized powder |
| Administration Route | Subcutaneous injection |
| Pharmaceutical Technology | Recombinant DNA production |
| Mechanism | Stimulates IGF-1 secretion |
| Therapeutic Category | Growth hormone therapy |
| Indications | Growth hormone deficiency |
| Reconstitution | Sterile diluent required |
| Absorption Pathway | Subcutaneous tissue absorption |
| Metabolic Breakdown | Proteolysis in liver and kidney |
| Elimination Route | Renal clearance |
| Packaging | Glass vial |
| Temperature Requirement | Refrigerated storage (2–8 °C) |
| Active Substance | Somatropin |
| Strength | 10 mg |
| Hormone Type | Recombinant human growth hormone |
| Protein Length | 191 amino acids |
| Molecular Weight | ≈22 kDa |
| Dosage Form | Lyophilized powder |
| Administration Route | Subcutaneous injection |
| Pharmaceutical Technology | Recombinant DNA production |
| Mechanism | Stimulates IGF-1 secretion |
| Therapeutic Category | Growth hormone therapy |
| Indications | Growth hormone deficiency |
| Reconstitution | Sterile diluent required |
| Absorption Pathway | Subcutaneous tissue absorption |
| Metabolic Breakdown | Proteolysis in liver and kidney |
| Elimination Route | Renal clearance |
| Packaging | Glass vial |
| Temperature Requirement | Refrigerated storage (2–8 °C) |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION